английский => русский Медицина Общественные науки, социология, этика и т.д. Interview/biosimilars

Evolving management of biosimilars

Interviewer script: In this section, we would like to understand your current perceptions of biosimilar products.

Are you anticipating the availability of mAb biosimilars in oncology indications in the next * years? If so, how will they be part of your evolving management objectives for the therapy area?

PROBES:
• Any particular molecules (***mab, ***mab, ***mab)
• Timeframe of expectations
• Alleviating budget impact, clinical characteristics (e.g. device, administration), additional services
• Increase affordable access

Спасибо!